These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38498979)
1. El-Habta R; Af Bjerkén S; Virel A Neurol Res; 2024 May; 46(5):406-415. PubMed ID: 38498979 [TBL] [Abstract][Full Text] [Related]
2. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release. Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513 [TBL] [Abstract][Full Text] [Related]
3. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line. Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048 [TBL] [Abstract][Full Text] [Related]
4. Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression. Magalingam KB; Somanath SD; Md S; Haleagrahara N; Fu JY; Selvaduray KR; Radhakrishnan AK Nutr Res; 2022 Feb; 98():27-40. PubMed ID: 35065349 [TBL] [Abstract][Full Text] [Related]
5. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Tiong CX; Lu M; Bian JS Br J Pharmacol; 2010 Sep; 161(2):467-80. PubMed ID: 20735429 [TBL] [Abstract][Full Text] [Related]
7. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. Clark J; Clore EL; Zheng K; Adame A; Masliah E; Simon DK PLoS One; 2010 Aug; 5(8):e12333. PubMed ID: 20808797 [TBL] [Abstract][Full Text] [Related]
8. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein. Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361 [TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146 [TBL] [Abstract][Full Text] [Related]
10. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models. Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Guo JT; Chen AQ; Kong Q; Zhu H; Ma CM; Qin C Cell Mol Neurobiol; 2008 Jan; 28(1):35-47. PubMed ID: 17985233 [TBL] [Abstract][Full Text] [Related]
13. Fenpropathrin, a Widely Used Pesticide, Causes Dopaminergic Degeneration. Xiong J; Zhang X; Huang J; Chen C; Chen Z; Liu L; Zhang G; Yang J; Zhang Z; Zhang Z; Lin Z; Xiong N; Wang T Mol Neurobiol; 2016 Mar; 53(2):995-1008. PubMed ID: 25575680 [TBL] [Abstract][Full Text] [Related]
14. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells. Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Watabe M; Nakaki T Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways. Yang X; Li Y; Chen L; Xu M; Wu J; Zhang P; Nel D; Sun B Pharm Biol; 2020 Dec; 58(1):686-694. PubMed ID: 32658590 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures. Ganser C; Papazoglou A; Just L; Nikkhah G Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells. Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517 [TBL] [Abstract][Full Text] [Related]
19. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons. Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298 [TBL] [Abstract][Full Text] [Related]